Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine
- 31 May 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (6-7) , 1085-1090
- https://doi.org/10.1016/0959-8049(92)90463-c
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- CLINICAL TRIALS OF ZIDOVUDINE IN HIV INFECTIONThe Lancet, 1989
- Study on the long-term toxic efficacy of cytosine-arabinoside in Sprague-Dawley ratsCancer Letters, 1988
- Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugsMathematical Biosciences, 1988
- The Effect of Drug Schedule on Responsiveness to ChemotherapyAnnals of the New York Academy of Sciences, 1987
- Pluripotent Haemopoietic Stem Cell Entry Into Dna Synthesis In Vitro After Stimulation By Ara-C Treatment In VivoCell Proliferation, 1986
- Cell Kinetic Behaviour of A Synchronized Population of Erythroid Precursor Cells in vitroCell Proliferation, 1984
- Quantitative cytokinetics: Cellular response to cell cycle specific agentsPharmacology & Therapeutics, 1983
- Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB originEuropean Journal of Immunology, 1977
- ARE CELL KINETIC DATA RELEVANT FOR THE DESIGN OF TUMOUR CHEMOTHERAPY SCHEDULES?Cell Proliferation, 1974
- Increased Tolerance of Leukemic Mice to Arabinosyl Cytosine with Schedule Adjusted to Circadian SystemScience, 1972